The historic rise of Viagra has long been a example of pharmaceutical success, but its legacy within the broader market now presents questions about long-term returns . Generic versions are eroding exclusivity , causing worries that investing in companies significantly dependent to Viagra's former standing could be a dangerous decision , especially